File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s00228-011-1183-4
- Scopus: eid_2-s2.0-84864286988
- PMID: 22166934
- WOS: WOS:000303452800037
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study
Title | Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study |
---|---|
Authors | |
Keywords | ADRs Children Inpatient Multicentre study Paediatric Risk factors |
Issue Date | 2012 |
Publisher | Springer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00228/index.htm |
Citation | European Journal Of Clinical Pharmacology, 2012, v. 68 n. 5, p. 801-810 How to Cite? |
Abstract | Background: Understanding the epidemiology and risk factors of adverse drug reactions (ADRs) is important in order to develop appropriate prevention strategies. This study aimed to identify risk factors associated with ADRs in hospitalised children and recommend strategies to minimise ADRs. Methods: A prospective multicentre cohort study was conducted on paediatric general medical wards in five European and non-European hospitals. ADRs were identified by intensive chart review. Multivariable logistic regression was used to investigate risk factors associated with ADRs. For the risk factor analysis, prescribed drugs were divided into high-risk and low-risk drug groups. Analgesics, anti-epileptics, antibacterials and antimycotics for systemic use, corticosteroids for systemic use and immunosuppressant agents were considered as high-risk groups whereas the remaining drug classes were defined as low-risk drug groups. Results: A total of 1,253 paediatric patients were identified [Australia (n0145), Germany (n0372), Hong Kong (n0 138), Malaysia (n0291), UK (n0307)]. A total of 328 ADRs were observed in 16.7% of patients (186/1,115). Use of five or more low-risk drugs per patient or three or more high-risk drugs was a strong predictor for ADRs (OR 4.7, 95% CI 2.4-9.3; OR 6.5, 95% CI 2.7-16.0 respectively; p<0.001). Older children were more likely to experience ADRs; gender was not significantly associated. Conclusion: To reduce the risk of ADRs in children, clinicians and pharmacists should aim to minimise polypharmacy and be aware of higher ADR risks associated with some drug groups. © Springer-Verlag 2011. |
Persistent Identifier | http://hdl.handle.net/10722/171449 |
ISSN | 2023 Impact Factor: 2.4 2023 SCImago Journal Rankings: 0.727 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rashed, AN | en_US |
dc.contributor.author | Wong, ICK | en_US |
dc.contributor.author | Cranswick, N | en_US |
dc.contributor.author | Tomlin, S | en_US |
dc.contributor.author | Rascher, W | en_US |
dc.contributor.author | Neubert, A | en_US |
dc.date.accessioned | 2012-10-30T06:14:19Z | - |
dc.date.available | 2012-10-30T06:14:19Z | - |
dc.date.issued | 2012 | en_US |
dc.identifier.citation | European Journal Of Clinical Pharmacology, 2012, v. 68 n. 5, p. 801-810 | en_US |
dc.identifier.issn | 0031-6970 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171449 | - |
dc.description.abstract | Background: Understanding the epidemiology and risk factors of adverse drug reactions (ADRs) is important in order to develop appropriate prevention strategies. This study aimed to identify risk factors associated with ADRs in hospitalised children and recommend strategies to minimise ADRs. Methods: A prospective multicentre cohort study was conducted on paediatric general medical wards in five European and non-European hospitals. ADRs were identified by intensive chart review. Multivariable logistic regression was used to investigate risk factors associated with ADRs. For the risk factor analysis, prescribed drugs were divided into high-risk and low-risk drug groups. Analgesics, anti-epileptics, antibacterials and antimycotics for systemic use, corticosteroids for systemic use and immunosuppressant agents were considered as high-risk groups whereas the remaining drug classes were defined as low-risk drug groups. Results: A total of 1,253 paediatric patients were identified [Australia (n0145), Germany (n0372), Hong Kong (n0 138), Malaysia (n0291), UK (n0307)]. A total of 328 ADRs were observed in 16.7% of patients (186/1,115). Use of five or more low-risk drugs per patient or three or more high-risk drugs was a strong predictor for ADRs (OR 4.7, 95% CI 2.4-9.3; OR 6.5, 95% CI 2.7-16.0 respectively; p<0.001). Older children were more likely to experience ADRs; gender was not significantly associated. Conclusion: To reduce the risk of ADRs in children, clinicians and pharmacists should aim to minimise polypharmacy and be aware of higher ADR risks associated with some drug groups. © Springer-Verlag 2011. | en_US |
dc.language | eng | en_US |
dc.publisher | Springer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00228/index.htm | en_US |
dc.relation.ispartof | European Journal of Clinical Pharmacology | en_US |
dc.rights | The original publication is available at www.springerlink.com | - |
dc.subject | ADRs | - |
dc.subject | Children | - |
dc.subject | Inpatient | - |
dc.subject | Multicentre study | - |
dc.subject | Paediatric | - |
dc.subject | Risk factors | - |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adolescent Development | en_US |
dc.subject.mesh | Asia - Epidemiology | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child Development | en_US |
dc.subject.mesh | Child, Preschool | en_US |
dc.subject.mesh | Cohort Studies | en_US |
dc.subject.mesh | Drug Toxicity - Epidemiology - Physiopathology - Prevention & Control | en_US |
dc.subject.mesh | Europe - Epidemiology | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Hospitals, General | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Incidence | en_US |
dc.subject.mesh | Infant | en_US |
dc.subject.mesh | Infant, Newborn | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Polypharmacy | en_US |
dc.subject.mesh | Prospective Studies | en_US |
dc.subject.mesh | Risk Factors | en_US |
dc.title | Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study | en_US |
dc.type | Article | en_US |
dc.identifier.email | Wong, ICK:wongick@hku.hk | en_US |
dc.identifier.authority | Wong, ICK=rp01480 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1007/s00228-011-1183-4 | en_US |
dc.identifier.pmid | 22166934 | - |
dc.identifier.scopus | eid_2-s2.0-84864286988 | en_US |
dc.identifier.hkuros | 207188 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-84864286988&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 68 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.spage | 801 | en_US |
dc.identifier.epage | 810 | en_US |
dc.identifier.isi | WOS:000303452800037 | - |
dc.publisher.place | Germany | en_US |
dc.identifier.scopusauthorid | Rashed, AN=54584268300 | en_US |
dc.identifier.scopusauthorid | Wong, ICK=7102513915 | en_US |
dc.identifier.scopusauthorid | Cranswick, N=6601977827 | en_US |
dc.identifier.scopusauthorid | Tomlin, S=7003861490 | en_US |
dc.identifier.scopusauthorid | Rascher, W=7102158639 | en_US |
dc.identifier.scopusauthorid | Neubert, A=7003774960 | en_US |
dc.identifier.citeulike | 10150098 | - |
dc.identifier.issnl | 0031-6970 | - |